Skip to main content
Back

EVS-EN ISO 10993-17:2023/A1:2025

Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/Amd 1:2025)

General information

Valid from 31.12.2025
Base Documents
ISO 10993-17:2023/Amd 1:2025; EN ISO 10993-17:2023/A1:2025
Directives or regulations
None

Standard history

Status
Date
Type
Name
15.01.2026
Main + amendment
31.12.2025
Amendment
01.12.2023
Main
Amendment to EN ISO 10993-17:2023

Required fields are indicated with *

*
*
*
PDF
12.40 € incl tax
Paper
12.40 € incl tax
Browse standard from 2.48 € incl tax
Standard monitoring

Customers who bought this item also bought

Main

EVS-EN ISO 10993-1:2026

Biological evaluation of medical devices - Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process (ISO 10993-1:2025)
Newest version Valid from 15.01.2026
Amendment

EVS-EN ISO 10993-23:2021/A1:2025

Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/Amd 1:2025)
Valid from 01.09.2025
Main + amendment

EVS-EN ISO 15223-1:2021+A1:2025

Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements (ISO 15223-1:2021 + ISO 15223 1:2021/Amd 1:2025)
Newest version Valid from 01.12.2025
Main + amendment

EVS-EN ISO 10993-5:2009+A11:2025

Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
Newest version Valid from 02.06.2025